Millennium Management LLC Increases Stake in Cabaletta Bio, Inc.
2026-02-18SEC Filing SCHEDULE 13G (0001104659-26-017121)
Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has reported acquiring a 5.3% stake in Cabaletta Bio, Inc. The total number of shares beneficially owned is 5,130,763. This filing, a Schedule 13G, indicates that the securities were not acquired for the purpose of influencing the control of the issuer. The filing was made on February 17, 2026, with the event date of the statement being February 11, 2026. The principal business office for the reporting persons is located at 399 Park Avenue, New York, New York 10022. The issuer's principal executive office is in Philadelphia, Pennsylvania.
Related industry:Biotechnology
Source:Original SEC Document â